Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio (2020 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Interest Coverage Ratio of 2.9 for Q1 2026, up 72.32% year-over-year from 1.68 in Q1 2025, and down 212.12% quarter-over-quarter from 2.59 in Q4 2025.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 2.9 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 72.32% year-over-year to 2.9; the TTM figure through Mar 2026 stood at 57.23 (down 115.7% YoY), while the FY2025 annual figure was 4.8, down 265.56% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.9, down from 2.59 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 2.59 in Q4 2025, with the low at 3894.65 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 56.62 (2022), against an average of 402.37.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio tumbled 3044.47% in 2024, then surged 113.08% in 2025.
- Syndax Pharmaceuticals' Interest Coverage Ratio stood at 1025.2 in 2022, then fell by 20.62% to 1236.59 in 2023, then surged by 98.4% to 19.76 in 2024, then jumped by 113.08% to 2.59 in 2025, then sank by 212.12% to 2.9 in 2026.
- Business Quant data shows SNDX's Interest Coverage Ratio at 2.9 in Q1 2026, 2.59 in Q4 2025, and 6.92 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn | -19,997.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19,997.50 |
| Jun 30, 2025 | -17,338.25 |
| Mar 31, 2025 | -41,878.50 |
| Dec 31, 2024 | 777.14 |
| Sep 30, 2024 | -3,894.65 |
| Jun 30, 2024 | -862.98 |
| Mar 31, 2024 | -913.95 |
| Dec 31, 2023 | -1,236.59 |
| Sep 30, 2023 | -805.07 |
| Jun 30, 2023 | -1,419.37 |
| Mar 31, 2023 | -1,150.38 |
| Dec 31, 2022 | -977.51 |
| Sep 30, 2022 | -20.10 |
| Jun 30, 2022 | -54.28 |
| Mar 31, 2022 | -56.62 |
| Dec 31, 2021 | -13,678.43 |
| Sep 30, 2021 | -30.87 |
| Jun 30, 2021 | -35.23 |
| Mar 31, 2021 | -43.60 |
| Dec 31, 2020 | -31.28 |